Uncategorised - European Medical Journal

Vision Loss Risk with Semaglutide Use - EMJ

Semaglutide Associated with Optic Neuropathy and Vision Loss

New study links semaglutide to rare optic nerve damage, highlighting the need for increased awareness, monitoring, and informed prescribing.

HIV and HCV cirrhosis immune markers linked to persistent portal hypertension after cure

Why Liver Pressure Can Persist After HCV Cure, Especially With HIV

Persistent portal hypertension after HCV cure characterized immunological mechanisms differing by HIV status in advanced cirrhosis.

Immunochemotherapy Timing Improves Survival - EMJ

Early Immunochemotherapy Timing Boosts Survival Outcomes

A Phase three trial shows early immunochemotherapy significantly improves survival and enhances CD8 T cell responses in advanced non small cell lung cancer.

Child with cystic fibrosis and gut health concept, illustrating short chain fatty acids and intestinal inflammation

Why Children with Cystic Fibrosis Face Ongoing Gut Inflammation

Children with cystic fibrosis showed lower short chain fatty acids, associated with dietary patterns and inflammation.

Turning Male Mosquitoes into Dengue Control - EMJ

Scientists Are Turning Male Mosquitoes into Dengue Control

Releasing male Aedes aegypti mosquitoes infected with Wolbachia cut wild mosquito numbers in Singapore and lowered dengue infection risk.

Clinician reviewing GPT-4 learning models in dermatology output on a laptop

GPT-4 Learning Models in Dermatology Rated Poor

GPT-4 learning models in dermatology demonstrated substandard information yet rarely offered harmful advice in evaluation, overall.

The SpA Puzzle: Unraveling Inflammation Piece by Piece

Why wait to control inflammation? Watch an ACR symposium with Iain McInnes on the clinical rationale for early control of inflammation in PsA and axSpA.

lymphoma

Repeat R CHOP Improves Late Relapse Lymphoma Outcomes

A second course of R CHOP achieved durable responses in late relapse diffuse large B cell lymphoma, especially in patients relapsing more than 5 years after diagnosis.

lung cancer in never smokers

Lung Cancer in Never Smokers Needs a New Approach

Lung cancer in never smokers is rising, with distinct risks and biology, highlighting the need for tailored screening, prevention, and treatment.

5 minutes with Dr Stefanie Rau, Nestlé Health Science

Stefanie Rau, Global Medical Affairs Manager, Healthy Ageing, unpacks why it’s never too early to invest in your health.